{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:14:11Z","timestamp":1774545251858,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204870"],"award-info":[{"award-number":["204870"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jcv.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T22:22:22Z","timestamp":1556490142000},"page":"58-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["New vaccines and antiviral drugs for cytomegalovirus"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9317-5915","authenticated-orcid":false,"given":"Paul","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcv.2019.04.007_bib0005","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy","volume":"12","author":"Atabani","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"8603","key":"10.1016\/j.jcv.2019.04.007_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(88)90685-X","article-title":"Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus","volume":"2","author":"Grundy","year":"1988","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcv.2019.04.007_bib0015","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1086\/514145","article-title":"Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation","volume":"176","author":"Cope","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"February(2)","key":"10.1016\/j.jcv.2019.04.007_bib0020","doi-asserted-by":"crossref","first-page":"ofz003","DOI":"10.1093\/ofid\/ofz003","article-title":"Correlation of cytomegalovirus (CMV) disease severity and mortality with CMV viral burden in CMV-Seropositive donor and CMV-Seronegative solid organ transplant recipients","volume":"6","author":"McBride","year":"2019","journal-title":"Open Forum Infect. Dis."},{"issue":"February(4)","key":"10.1016\/j.jcv.2019.04.007_bib0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cid\/cix793","article-title":"Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis","volume":"66","author":"Natori","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.jcv.2019.04.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163722","article-title":"Randomized controlled trials to define viral load thresholds for cytomegalovirus pre-emptive therapy","volume":"11","author":"Griffiths","year":"2016","journal-title":"PLoS One"},{"issue":"August(4)","key":"10.1016\/j.jcv.2019.04.007_bib0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jcv.2019.04.007_bib0040","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/AAC.00577-06","article-title":"Maribavir antagonizes the antiviral action of ganciclovir on human cytomegalovirus","volume":"50","author":"Chou","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.jcv.2019.04.007_bib0045","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2019.04.007_bib0050","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"Chemaly","year":"2014","journal-title":"New. Engl. J. Med."},{"issue":"June (3)","key":"10.1016\/j.jcv.2019.04.007_bib0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/tid.12542","article-title":"Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants","volume":"18","author":"Panagou","year":"2016","journal-title":"Transplant Infect. Dis."},{"issue":"11","key":"10.1016\/j.jcv.2019.04.007_bib0060","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1182\/blood-2007-11-121558","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem-cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study","volume":"111","author":"Winston","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcv.2019.04.007_bib0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.coviro.2011.10.011","article-title":"Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?","volume":"1","author":"Marty","year":"2011","journal-title":"Curr. Opin. Virol."},{"issue":"4","key":"10.1016\/j.jcv.2019.04.007_bib0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial","volume":"11","author":"Marty","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"February (2)","key":"10.1016\/j.jcv.2019.04.007_bib0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbmt.2018.09.038","article-title":"A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation","volume":"25","author":"Marty","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"December(25)","key":"10.1016\/j.jcv.2019.04.007_bib0080","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8376","key":"10.1016\/j.jcv.2019.04.007_bib0085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(84)90930-9","article-title":"Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants","volume":"1","author":"Plotkin","year":"1984","journal-title":"Lancet"},{"issue":"January(1)","key":"10.1016\/j.jcv.2019.04.007_bib0090","article-title":"Criteria to define interruption of transmission of human cytomegalovirus from organ donor to recipient","volume":"28","author":"Baraniak","year":"2018","journal-title":"Rev. Med. Virol."},{"issue":"9773","key":"10.1016\/j.jcv.2019.04.007_bib0095","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"issue":"February (2)","key":"10.1016\/j.jcv.2019.04.007_bib0100","article-title":"Phase 2 randomized, double-blind, placebo-controlled trial of RG7667, a combination monoclonal antibody, for prevention of cytomegalovirus infection in high-risk kidney transplant recipients","volume":"61","author":"Ishida","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"May (10)","key":"10.1016\/j.jcv.2019.04.007_bib0105","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cit048","article-title":"Complex correlates of protection after vaccination","volume":"56","author":"Plotkin","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"May 9","key":"10.1016\/j.jcv.2019.04.007_bib0110","article-title":"A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor","author":"Vincenti","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"June(3)","key":"10.1016\/j.jcv.2019.04.007_bib0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/tid.12205","article-title":"Transient residence of a seropositive organ is sufficient to transfer human cytomegalovirus to a seronegative recipient","volume":"16","author":"Lumgair","year":"2014","journal-title":"Transplant Infect. Dis."},{"issue":"8477","key":"10.1016\/j.jcv.2019.04.007_bib0120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(86)92315-9","article-title":"Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow","volume":"1","author":"Wimperis","year":"1986","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jcv.2019.04.007_bib0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect. Dis."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219300952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219300952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T11:42:07Z","timestamp":1607427727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653219300952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":25,"alternative-id":["S1386653219300952"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2019.04.007","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New vaccines and antiviral drugs for cytomegalovirus","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}